Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Fujisawa discloses antiplatelet agents

Dec. 24, 1996

New antiplatelet drugs from Takeda

Dec. 23, 1996

New antithrombotic agents described by Pfizer

Dec. 23, 1996

Corvas and Schering-Plough expand antithrombotic collaboration

Dec. 18, 1996

New antiplatelet agents described by Thomae

Dec. 17, 1996

FDA panel recommends approval of BeneFix

Dec. 13, 1996

DuPont Merck reports pharmacokinetic data for novel gpIIb/IIIa antagonist

Dec. 13, 1996

Novel mechanism of action reported for Xenova PAI inhibitor

Dec. 13, 1996

Warfarin underused for stroke prevention

Dec. 11, 1996

Antithrombin III advances to phase II

Dec. 11, 1996

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...